An autologous bone marrow transplant (auto-BMT) is a treatment in which a patient’s own blood-forming stem cells are collected, stored, and later returned after high-dose chemotherapy or other intensive treatment. It is commonly considered for conditions such as multiple myeloma, lymphoma, and selected other blood-related cancers, depending on the individual’s diagnosis and treatment plan.
How the Treatment Works
The process generally begins with medicines that stimulate stem-cell production, followed by stem cell collection through a blood-filtering procedure called apheresis. The collected cells are preserved while the patient receives conditioning treatment. The stored stem cells are then infused back into the bloodstream to help restore healthy blood-cell production.
Benefits and Recovery
The potential benefits of an autologous stem cell transplant include enabling intensive treatment when appropriate and supporting recovery of the bone marrow afterward. Because the stem cells come from the patient, there is no donor matching requirement and the risk of graft-versus-host disease is generally avoided.
Recovery varies depending on the underlying condition, treatment intensity, age, and overall health. Patients may require close monitoring for infections, low blood counts, fatigue, nausea, and other treatment-related effects. The transplant team provides personalized guidance on nutrition, infection prevention, medications, follow-up visits, and recovery.
Who May Be Suitable?
Suitability for autologous bone marrow transplantation is determined after evaluating the diagnosis, previous treatments, organ function, fitness, and overall medical condition. A hematologist or transplant specialist can explain whether this treatment is appropriate and what patients can expect throughout the transplant journey.